Defendants in this lawsuit are C.R. Bard, Inc., Sofradim Production SAS, and Tissue Science Laboratories. C.R. Bard his its principal corporate headquaters located in New Jersey, Sofradim is a French Corporation, and Tissue Science Laboratories is a British company.
Plaintiffs have filed lawsuits claiming that one or more of the Defendant’s Pelvic Mesh Implant Products, which were implanted to treat Pelvic Organ Prolapse and Stress Urinary Incontinence, have failed and caused severe complications. Many of the plaintiff’s have included their spouses in the lawsuit for loss of consortium caused by these complications.
The plaintiffs allege that the trans-vaginal products are defective in that they are biologically incompatible with human tissue and promote a negative immune response in a large subset of the population implanted with Defendants mesh implant devices.
These women have endured years of chronic pain and loss of normal functional activities, which are a result of the mesh causing problems with nerves, infection, extrusion through tissue, disintegration, organ perforation, and many other complications including the loss of ability to engage in sexual relations.
In addition to the defective design the plaintiffs also allege that the defendants failed to warn of the dangers associated with the devices when they aggressively sold and marketed their expensive equipment to hospitals and doctors.
The names of the mesh implants in this lawsuit are:
a. The Align Urethral Support System;
b. The Align TO Urethral Support System;
c. The Avaulta Anterior BioSynthetic Support System;
d. The Avaulta Posterior BioSynthetic Support System;
e. The Avaulta Plus Anterior BioSynthetic Support System;
f. The Avaulta Plus Posterior BioSynthetic Support System;
g. The Avaulta Solo Anterior Synthetic Support System;
h. The Avaulta Solo Posterior Synthetic Support System;
i. The InnerLace BioUrethral Support System;
j. The Pelvicol Acellular Collagen Matrix;
k. The PelviLace BioUrethral Support System;
l. The PelviLace TO Trans-obturator BioUrethral Support System;
m. The PelviSoft Acellular Collagen BioMesh;
n. The Pelvitex Polypropylene Mesh;
o. The Uretex SUP Pubourethral Sling;
p. The Uretex TO Trans-obturator Urethral Support System;
q. The Uretex TO2 Trans-obturator Urethral Support System; and
r. The Uretex TO3 Trans-obturator Urethral Support System.